These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17822346)

  • 1. Risperidone-induced enuresis in two children with autistic disorder.
    Hergüner S; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):527-30. PubMed ID: 17822346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.
    Harrison-Woolrych M; Skegg K; Ashton J; Herbison P; Skegg DC
    Br J Psychiatry; 2011 Aug; 199(2):140-4. PubMed ID: 21653944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation.
    Kumazaki H; Watanabe K; Imasaka Y; Iwata K; Tomoda A; Mimura M
    J Clin Psychopharmacol; 2014 Oct; 34(5):624-6. PubMed ID: 25118082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine for enuresis associated with risperidone.
    Hergüner S; Hergüner A; Küçükapan HU
    J Clin Psychopharmacol; 2011 Dec; 31(6):782-3. PubMed ID: 22051922
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose Aripiprazole Induced Enuresis Continuum in a Child.
    Karatoprak S; Uzun N
    Clin Neuropharmacol; 2020; 43(4):123-124. PubMed ID: 32541331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine.
    Mergui J; Jaworowski S
    Clin Neuropharmacol; 2016; 39(3):152-3. PubMed ID: 26992158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole-Related Diurnal Enuresis in Children: 2 Cases (Aripiprazole-Related Enuresis).
    Gunes S
    Clin Neuropharmacol; 2017; 40(4):175-176. PubMed ID: 28622211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin Use in the Treatment of Aripiprazole-Induced Nocturnal Enuresis in a Child Diagnosed with Autıstıc Disorder.
    Karakurt MN; Süren S
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):518-9. PubMed ID: 26222623
    [No Abstract]   [Full Text] [Related]  

  • 12. Enuresis with combined risperidone and SSRI use.
    Took KJ; Buck BJ
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):840-1. PubMed ID: 8768340
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
    Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
    Zuddas A; Di Martino A; Muglia P; Cianchetti C
    J Child Adolesc Psychopharmacol; 2000; 10(2):79-90. PubMed ID: 10933118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term safety and tolerability of risperidone in children with autism.
    Aman MG; Arnold LE; McDougle CJ; Vitiello B; Scahill L; Davies M; McCracken JT; Tierney E; Nash PL; Posey DJ; Chuang S; Martin A; Shah B; Gonzalez NM; Swiezy NB; Ritz L; Koenig K; McGough J; Ghuman JK; Lindsay RL
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):869-84. PubMed ID: 16379507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications.
    Lasser RA; Mao L; Gharabawi G
    Schizophr Res; 2004 Feb; 66(2-3):163-7. PubMed ID: 15061249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.